June 2018


Clinical Conversation Corticosteroids for DME: Lessons from Protocol U

Our expert panel parses how the DRCRnet trial informs how they use of corticosteroids in diabetic macular edema. Part 2 of 2.

Retina Standouts from ARVO 2018 Novel Treatments for RP, CSC and More

Promising results of topical treatment for macular holes, non-drug anesthesia for IVT and RRD repair without prone positioning.

Quality of Life and Vitreoretinal Interventions

Payers want to know how much that medical intervention improves a patient’s life. There’s a way to measure that.

SCORE2 Lessons for Treatment Of ME due to CRVO or HRVO

This study provides Level 1 evidence that bevacizumab and aflibercept have similar visual acuity outcomes in patients with macular edema associated with central or hemi-retinal vein occlusion.

ERM Pathogenesis: Three Theories Suggest Defects of Vitreous and ILM

Controversy surrounds the causes of idiopathic epiretinal membrane, but the dominant theories are not necessarily mutually exclusive.


Clinical Trial Closeup

A Smaller, Faster Anti-VEGF Therapy

How brolucizumab may extend dosing out to 12 weeks.

Coding Commentary

Yet Another Medicare Audit Process

Here’s what you can expect from and how you can prepare for a Targeted Probe and Education review.

Editor's Page


Retina Rounds

Retinal Pathology with Glaucoma

Is macular schisis and serous retinal detachment a coincidence or contribution from the optic nerve head?

Surgical Pearl Video

Modified ILM Flap for Refractory Holes

A modified approach to internal limiting membrane flaps in eyes with a previous ILM peel.